FDA Investigator Khoa Nathanv Tran
Khoa Nathanv Tran has inspections in 3 countries as of 15 Sep 2023. Khoa Nathanv Tran has collaborated with a combined 1773 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
28
Last Inspection Date:
15 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Mexico,
United States of America,
Japan
Co-Investigator(s):
Andrew Le,
Andy B Lee,
Angela E Glenn,
Anna Lazar,
Ariel Cruz Figueroa,
Arsen Karapetyan,
Ashar P Parikh,
Babajide Michael Osunsanmi,
Barbara J Rincon,
Binh T Nguyen,
Bryan A Galvez,
Bryce A Hammer,
Carla J Lundi,
Carr Sharpe,
Caryn M Everly,
Caryn M Mcnab,
Charles M Edwards,
Chelsea N Sealey,
Christopher R Czajka,
Crystal Monroy,
Cynthia A Palmer,
Daniel R Solis,
Darren S Brown,
David Serrano,
Diana L Ayala,
Diana M Rand,
Diane Cvan Leeuwen,
Dogbeda F Mackenzie,
Dr. Robert C Horan, MD,
Ginger M Sykes,
Gloria J Baca, MS,
Hung H Do, MS,
James C Maclaughlin,
Jane S Wernberg,
Jeffrey P Raimondi,
Jennifer M Gogley,
Jinnie Kokiatkulkij,
Jocelyn E Massey,
Jocelyn E Sparks,
Joey V Quitania,
John A Gonzalez,
John D White,
John R Myung,
Kari M Johansen,
Katherine E Jacobitz,
Kelley,
Kelvin Cheung,
Kelvin X Sanders,
Kham Phommachanh,
Lance A Finnical,
Langer,
Laura A Munsterman,
Leonard H Lavi,
Lillian S Wu,
Liming Zhang,
Linda Thai,
Lisa Shin,
Louis B Cencetti,
Louise B Cencetti,
Marcus F Yambot,
Marie Falcone,
Marie T Falcone,
Marijo B Kambere, PhD,
Mark A Tucker,
Mark C Saale,
Matthew J Johnson,
Michael D Garcia,
Michele L Obert,
Mihaly S Ligmond,
Nancy E Byerly,
Nicholas L Hunt,
Rachel C Stanton,
Randall N Johnson,
Raymond T Oji,
Richard E Needham,
Richmond K Yip,
Robert C Coleman,
Roger F Zabinski,
Rory K Geyer,
Rowena S Nguyen,
Saied A Asbagh,
Sara H Gabel,
Sarah M Meng,
Sarah M Napier,
Scott N Lim,
Sonia R Peterson,
Sonya L Karsik,
Stephanie A Slater, MS,
Sudipan Karmakar,
Susan W Ting,
Taichun Qin, PhD,
Tamala P Magee,
Ted L Anderson,
Terri L Dodds,
Theresa Kirkham (NMI),
Timothy T Kapsala,
Uttaniti Limchumroon (Tom),
Virgilio F Pacio, CSO,
Wenzheng Zhang,
William J Leonard,
Yasamin Ameri,
Yumi J Hiramine,
Yvette Mlacour Davis,
Zachary A Bogorad
Khoa Nathanv Tran's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more